Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Biogen Idec (BIIB)

2014-11-25@10:47:20 ET
Potential Biogen Idec (BIIB) Trade Targets 4.40% Return (FBM)

2014-11-24@16:47:44 ET
Watch for Biogen Idec to Potentially Pullback After Gaining 1.05% Yesterday (PSM)

2014-11-24@16:47:14 ET
Biogen Idec Set to Possibly Pullback After Yesterday's Rally of 1.05% (PSM)

2014-11-24@13:30:00 ET
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients (PRN)

2014-11-24@10:57:19 ET
Watch for Shares of Biogen Idec (BIIB) to Approach Resistance at $307.34 (F79)

2014-11-24@08:40:47 ET
Potential Biogen Idec (BIIB) Trade Has 5.34% Downside Protection (FBM)

2014-11-22@07:10:29 ET
Novavax Gains on Fast Track Designation for RSV F Vaccine (ZAX)

2014-11-21@09:49:50 ET
Biogen Idec (BIIB) Showing Bearish Technicals With Support At $294.15 (FBM)

2014-11-21@08:11:43 ET
Analysis of Relative Performance in the Biotechnology Industry for Shares of MannKind (MNKD, NBIX, REGN, GILD, BIIB) (F70)

2014-11-21@02:01:50 ET
Sobi exercises opt-in right for Elocta(TM) (HUG)

2014-11-20@16:42:14 ET
Biogen Idec Falls 1.49% on Heavy Volume: Watch For Potential Rebound (PSM)

2014-11-20@16:41:41 ET
After Yesterday's Decline of 1.49%, Biogen Idec Offers Investors Better Value (PSM)

2014-11-20@13:51:11 ET
Biogen Idec (BIIB) Showing Bearish Technicals With Resistance At $307.14 (FBM)

2014-11-20@10:37:44 ET
Biogen Idec (BIIB) Crosses Pivot Point Support at $301.97 (F79)

2014-11-20@09:28:34 ET
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight Report (MTO)

2014-11-20@08:00:12 ET
Vital Therapies Expands Management Team (PMZ)

2014-11-19@16:01:11 ET
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference (BIZ)